{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:43:02Z","timestamp":1790390582115,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of L\u00fcbeck, German Systemic Sclerosis Network (DNSS)","award":["RI 1056-11-1\/2"],"award-info":[{"award-number":["RI 1056-11-1\/2"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.autrev.2016.03.005","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T02:02:36Z","timestamp":1457575356000},"page":"690-694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis"],"prefix":"10.1016","volume":"15","author":[{"given":"Otavio","family":"Cabral-Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Riemekasten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2016.03.005_bb0005","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2016.03.005_bb0010","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an american college of rheumatology\/European league against rheumatism collaborative initiative","volume":"65","author":"Van Den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.005_bb0015","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0889-857X(05)70300-8","article-title":"Raynaud's phenomenon","volume":"22","author":"Wigley","year":"1996","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2016.03.005_bb0020","article-title":"Vasoactive therapy in systemic sclerosis: real-life therapeutic practice in more than 3000 patients","author":"Moinzadeh","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.03.005_bb0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0049-0172(75)90017-7","article-title":"Pathogenesis of systemic sclerosis: a vascular hypothesis","volume":"4","author":"Campbell","year":"1975","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.005_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0190-9622(80)80396-3","article-title":"Capillary alterations in scleroderma","volume":"2","author":"Fleischmajer","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2016.03.005_bb0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1365-2249.2001.01603.x","article-title":"Circulating gamma\/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization","volume":"125","author":"Giacomelli","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2016.03.005_bb0040","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-015-0513-5","article-title":"Functional autoantibodies in systemic sclerosis","volume":"37","author":"G\u00fcnther","year":"2015","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2016.03.005_bb0045","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.03.005_bb0050","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2016.03.005_bb0055","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI4106","article-title":"Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor","volume":"103","author":"Wallukat","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2016.03.005_bb0060","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.autrev.2016.03.005_bb0065","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1146\/annurev.pharmtox.47.120505.105134","article-title":"Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease","volume":"47","author":"Schneider","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.autrev.2016.03.005_bb0070","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3899\/jrheum.150061","article-title":"Autoantibodies against endothelin 1 type A receptor are strong predictors of digital ulcers in systemic sclerosis","volume":"42","author":"Avouac","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.03.005_bb0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/edrv.21.1.0390","article-title":"Uncovering molecular mechanisms involved in activation of G protein-coupled receptors","volume":"21","author":"Gether","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.autrev.2016.03.005_bb0080","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar4503","article-title":"Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients","volume":"16","author":"G\u00fcnther","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.03.005_bb0085","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar4457","article-title":"Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis","volume":"16","author":"Kill","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.03.005_bb0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archderm.1993.01680230073008","article-title":"Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders","volume":"129","author":"Reitamo","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2016.03.005_bb0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1381612805666230109213039","article-title":"Interleukin-8: an autocrine inflammatory mediator","volume":"5","author":"Atta-ur-Rahman","year":"1999","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.autrev.2016.03.005_bb0100","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","article-title":"Role of transforming growth factor beta in human disease","volume":"342","author":"Blobe","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2016.03.005_bb0105","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/rheumatology\/kep091","article-title":"The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1","volume":"48","author":"Rabquer","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.03.005_bb0110","first-page":"1566","article-title":"Significance of plasma endothelin-1 levels in patients with systemic sclerosis","volume":"19","author":"Yamane","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.03.005_bb0115","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/art.1780340807","article-title":"Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. enhanced production and profibrotic action","volume":"34","author":"Kahaleh","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.005_bb0120","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","article-title":"Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis","volume":"190","author":"Becker","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2016.03.005_bb0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jash.2008.09.002","article-title":"Vascular smooth muscle cell signaling mechanisms for contraction to angiotensin II and endothelin-1","volume":"3","author":"Wynne","year":"2009","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.autrev.2016.03.005_bb0130","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/01.RES.0000216596.73005.3c","article-title":"Excitation-transcription coupling in arterial smooth muscle","volume":"98","author":"Wamhoff","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2016.03.005_bb0135","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nrm2803","article-title":"Fine-tuning of GPCR activity by receptor-interacting proteins","volume":"10","author":"Ritter","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.autrev.2016.03.005_bb0140","first-page":"831","article-title":"Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease","volume":"151","author":"Abraham","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2016.03.005_bb0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/HYPERTENSIONAHA.111.171348","article-title":"Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats","volume":"58","author":"Wenzel","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.autrev.2016.03.005_bb0150","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/01.CIR.0000058200.90059.B1","article-title":"AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase","volume":"107","author":"Dechend","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.03.005_bb0155","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1128\/MCB.24.17.7806-7819.2004","article-title":"NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity","volume":"24","author":"Fujioka","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.autrev.2016.03.005_bb0160","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1136\/ard.2007.079921","article-title":"Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases","volume":"67","author":"Denton","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.03.005_bb0165","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJM197906213002505","article-title":"Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade","volume":"300","author":"Lopez-Ovejero","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2016.03.005_bb0170","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1161\/01.CIR.102.19.2434","article-title":"Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs","volume":"102","author":"Luscher","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.03.005_bb0175","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/art.37969","article-title":"Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies","volume":"65","author":"Onishi","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.005_bb0180","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrc3546","article-title":"Endothelin 1 in cancer: biological implications and therapeutic opportunities","volume":"13","author":"Rosan\u00f2","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.autrev.2016.03.005_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035667","article-title":"Angiotensin II facilitates breast cancer cell migration and metastasis","volume":"7","author":"Rodrigues-Ferreira","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.03.005_bb0190","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2016.03.005_bb0195","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/ijcp.12242","article-title":"The role of angiotensin II type 1 receptor-activating antibodies in patients with lupus nephritis","volume":"67","author":"Xiong","year":"2013","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.autrev.2016.03.005_bb0200","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1002\/art.39212","article-title":"Anti-endothelin receptor type A autoantibodies in systemic lupus erythematosus-associated pulmonary arterial hypertension","volume":"67","author":"Guo","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2016.03.005_bb0205","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.amjhyper.2004.10.002","article-title":"Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion","volume":"18","author":"Bobst","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.autrev.2016.03.005_bb0210","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00004872-200018070-00017","article-title":"Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension","volume":"18","author":"Fu","year":"2000","journal-title":"J Hypertens"},{"key":"10.1016\/j.autrev.2016.03.005_bb0215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1757-2215-6-22","article-title":"Serum agonistic autoantibodies against type-1 angiotensin II receptor titer in patients with epithelial ovarian cancer: a potential role in tumor cell migration and angiogenesis","volume":"6","author":"Song","year":"2013","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.autrev.2016.03.005_bb0220","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000365782","article-title":"Autoantibodies against \u03b21 receptor and AT1 receptor in type 2 diabetes patients with left ventricular dilatation","volume":"129","author":"Zhao","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.autrev.2016.03.005_bb0225","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-0034-1370920","article-title":"Relationship between autoantibody to the angiotensin II-1 receptor and cardiovascular manifestations of Graves' disease","volume":"122","author":"Xu","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.autrev.2016.03.005_bb0230","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1024\/0301-1526\/a000372","article-title":"G-protein coupled receptor auto-antibodies in thromboangiitis obliterans (Buerger's disease) and their removal by immunoadsorption","volume":"43","author":"Klein-Weigel","year":"2014","journal-title":"Vasa"},{"key":"10.1016\/j.autrev.2016.03.005_bb0235","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcf.2014.07.007","article-title":"Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis","volume":"14","author":"Budding","year":"2015","journal-title":"J Cyst Fibros"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216300532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216300532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T18:24:45Z","timestamp":1748802285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216300532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1568997216300532"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.03.005","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}